scirpusin B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 5458999 |
CHEMBL ID | 514088 |
SCHEMBL ID | 15440888 |
MeSH ID | M0543356 |
Synonym |
---|
scirpusin b |
nsc-600679 |
NSC600679 , |
4-[(e)-2-[2-(3,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2,3-dihydro-1-benzofuran-4-yl]ethenyl]benzene-1,2-diol |
CHEMBL514088 |
1,2-benzenediol, 4-(2-(2-(3,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-2,3-dihydro-6-hydroxy-4-benzofuranyl)ethenyl)- |
69297-49-0 |
1,2-benzenediol,4-[(1z)-2-[(2s,3s)-2-(3,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-2,3-dihydro-6-hydroxy-4-benzofuranyl]ethenyl]- |
SCHEMBL15440888 |
(e)-4-(2-(2-(3,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2,3-dihydrobenzofuran-4-yl)vinyl)benzene-1,2-diol |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID337729 | Cytotoxicity against mouse 3PS cells xenografted in mouse at 18 mg/kg relative to control | |||
AID337732 | Antifeedant activity against Spodoptera frugiperda assessed as feeding ratio for 5 seconds | |||
AID337731 | Toxicity in Artemia salina | |||
AID337733 | Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumor assessed as tumor inhibition in potato tubers by potato disk assay relative to control | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.05) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |